Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Monica Chanda & Mark S. Cohen. (2021) Advances in the discovery and development of melanoma drug therapies. Expert Opinion on Drug Discovery 16:11, pages 1319-1347.
Read now
Read now
Wei Ji, Lanfang Li, Shiyong Zhou, Lihua Qiu, Zhengzi Qian, Huilai Zhang & Peiqi Zhao. (2020) Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response. Journal of Drug Targeting 28:9, pages 982-990.
Read now
Read now
Articles from other publishers (14)
Jumin Huang, Fugang Duan, Chun Xie, Jiahui Xu, Yizhong Zhang, Yuwei Wang, Yu‐Ping Tang & Elaine Lai‐Han Leung. (2023) Microbes mediated immunogenic cell death in cancer immunotherapy. Immunological Reviews.
Crossref
Crossref
I. Anestopoulos, S. Kyriakou, V. Tragkola, I. Paraskevaidis, E. Tzika, M. Mitsiogianni, M.V. Deligiorgi, G. Petrakis, D.T. Trafalis, S. Botaitis, A. Giatromanolaki, M.I. Koukourakis, R. Franco, A. Pappa & M.I. Panayiotidis. (2022) Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacology & Therapeutics 240, pages 108301.
Crossref
Crossref
Dale Han, Alexander C. J. van Akkooi, Richard J. StrakerIIIIII, Adrienne B. Shannon, Giorgos C. Karakousis, Lin Wang, Kevin B. Kim & Douglas Reintgen. (2021) Current management of melanoma patients with nodal metastases. Clinical & Experimental Metastasis 39:1, pages 181-199.
Crossref
Crossref
Sauson Soldozy, Kathleen M. Mulligan, David X. Zheng, Melissa A. Levoska, Christopher R. Cullison, Turki Elarjani, Daniel G. Eichberg, Leonel E. Ampie, Ashish H. Shah, Kaan Yağmurlu, Mark E. Shaffrey, Jeffrey F. Scott & Ricardo J. Komotar. (2021) Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm?. Brain Sciences 11:10, pages 1260.
Crossref
Crossref
Mariangela Garofalo, Laura Bertinato, Monika Staniszewska, Magdalena Wieczorek, Stefano Salmaso, Silke Schrom, Beate Rinner, Katarzyna Wanda Pancer & Lukasz Kuryk. (2021) Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model. Pharmaceutics 13:4, pages 547.
Crossref
Crossref
Trevor S. Anderson, Amanda L. Wooster, Ninh M. La-Beck, Dipongkor Saha & Devin B. Lowe. (2020) Antibody-drug conjugates: an evolving approach for melanoma treatment. Melanoma Research 31:1, pages 1-17.
Crossref
Crossref
Reinhard Merz. (2020) Onkolytische Viren. TumorDiagnostik & Therapie 41:07, pages 445-447.
Crossref
Crossref
Claudia Robles-Planells, Carlos Barrera-Avalos, Leonel E. Rojo, Eugenio Spencer, Marcelo Cortez-San Martin, Silvia Matiacevich, Jorge Pavez, Luis A. Milla, Franco D. Navarro, Brandon A. Martínez, Francisco J. Bravo, Andrea Mella, Juan Pablo Huidobro-Toro, Ricardo Fernandez, Alejandro Escobar & Claudio Acuña-Castillo. (2020)
Chitosan-Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene:
In Vitro
and
In Vivo
Studies towards a New Vaccine against Melanoma
. BioMed Research International 2020, pages 1-11.
Crossref
Crossref
Claudia Robles-Planells, Giselle Sánchez-Guerrero, Carlos Barrera-Avalos, Silvia Matiacevich, Leonel E. Rojo, Jorge Pavez, Edison Salas-Huenuleo, Marcelo J. Kogan, Alejandro Escobar, Luis A. Milla, Ricardo Fernandez, Mónica Imarai, Eugenio Spencer, Juan Pablo Huidobro-Toro & Claudio Acuña-Castillo. (2020) Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies. Mediators of Inflammation 2020, pages 1-13.
Crossref
Crossref
Mitra Nair, Maninder Khosla, Yoshihiro Otani, Margaret Yeh, Flora Park, Toshihiko Shimizu, Jin Muk Kang, Chelsea Bolyard, Jun-Ge Yu, Yeshavanth Kumar Banasavadi-Siddegowda, Gonzalo Lopez, Balveen Kaur, Raphael E. Pollock, Tae Jin Lee, Matthew Old & Ji Young Yoo. (2020) Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation. Cancers 12:4, pages 1040.
Crossref
Crossref
David Ruano, José A. López-Martín, Lucas Moreno, Álvaro Lassaletta, Francisco Bautista, Maitane Andión, Carmen Hernández, África González-Murillo, Gustavo Melen, Ramón Alemany, Luis Madero, Javier García-Castro & Manuel Ramírez. (2020) First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors. Molecular Therapy 28:4, pages 1033-1042.
Crossref
Crossref
Megan H. Trager, Larisa J. Geskin & Yvonne M. Saenger. (2020) Oncolytic Viruses for the Treatment of Metastatic Melanoma. Current Treatment Options in Oncology 21:4.
Crossref
Crossref
Yonghyo Kim, Jeovanis Gil, Indira Pla, Aniel Sanchez, Lazaro Hiram Betancourt, Boram Lee, Roger Appelqvist, Christian Ingvar, Lotta Lundgren, Håkan Olsson, Bo Baldetorp, Ho Jeong Kwon, Henriett Oskolás, Melinda Rezeli, Viktoria Doma, Sarolta Kárpáti, A. Marcell Szasz, István Balázs Németh, Johan Malm & György Marko-Varga. (2020) Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes. Cancers 12:3, pages 767.
Crossref
Crossref
Hima Patel, Nour Yacoub, Rosalin Mishra, Aaron White, Long Yuan, Samar Alanazi & Joan T. Garrett. (2020) Current Advances in the Treatment of BRAF-Mutant Melanoma. Cancers 12:2, pages 482.
Crossref
Crossref